Large real world studies often rely on billing codes and incomplete weight records, which can obscure the natural ups and downs of weight and adherence
Meta-analyses of berberine trials show modest reductions in hemoglobin A1c (approximately 0.5-0.7%) and fasting glucose, with variable effects on body weight, though many studies have methodological limitations and high heterogeneity
The STEP (Semaglutide Treatment Effect in People with obesity) 1 trial was a randomized, placebo-controlled trial that evaluated the efficacy of once-weekly subcutaneous (SC) semaglutide 2.4 mg plus lifestyle interventions in adults with obesity without diabetes (n = 1961)
Combining lifestyle changes with GLP-1 therapy enhances long-term outcomes
[3] [4] [6] [14] [9] The goal is not to create fear around an effective class of medications
We used line-by-line sequential scanning with laser excitation lines 405 for DAPI, 488 nm for Alexa Fluor 488, 561 nm for Alexa Fluor 555 or Cy3, and 633 nm for Alexa 647 or Cy5, with MBS 488/561/633 and MBS -405 beamsplitters